Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, … Read more
North America Rapid Diagnostics is projected to grow by 6.5% annually in the forecast period and reach $29,905.4 million by 2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding … Read more
Europe Rapid Diagnostics was valued at $ 9,950.1 million in 2021 and will grow by 5.6% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis … Read more
Asia Pacific Rapid Diagnostics will grow by 10.9% annually with a total addressable market cap of $ 129,373.7 million over 2022-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding … Read more
Global Sleep Aids market will reach $159,756.6 million by 2031, growing by 6.7% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of … Read more
Europe Sleep Aids market was valued at $ 22,840.5 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, … Read more
Asia Pacific Sleep Aids market will grow by 8.5% annually with a total addressable market cap of $325,998.9 billion over 2022-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public … Read more
Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures.Highlighted with 83 tables and … Read more
North America small molecule contract development and manufacturing organization (CDMO) market is projected to grow by 5.3% annually in the forecast period and reach $ 42,793.3 million by 2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and … Read more
Europe small molecule contract development and manufacturing organization (CDMO) market was valued at $ 17,340.6 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures.Highlighted … Read more